Fatal brain infection caused by Aspergillus glaucus in an immunocompetent patient identified by sequencing of the ribosomal 18S–28S internal transcribed spacer

  • R. S. Traboulsi
  • M. M. Kattar
  • O. Dbouni
  • G. F. Araj
  • S. S. Kanj
Case Report

Abstract

Cerebral aspergillosis has rarely been reported in immunocompetent patients. We herein describe a unique case of cerebral aspergillosis in a healthy adult that led to his death despite aggressive antifungal therapy. Sequencing of ribosomal 18S–28S internal transcribed spacer identified the organism as Eurotium herbariorum, the teleomorph of Aspergillus glaucus.

References

  1. 1.
    Paterson DL (2004) New clinical presentations of invasive aspergillosis in non-conventional hosts. Clin Microbiol Infect 10(Suppl 1):24–30PubMedCrossRefGoogle Scholar
  2. 2.
    Salaki JS, Lourira DB, Chmel H (1984) Fungal and yeast infections of the central nervous system: a clinical review. Medicine (Baltimore) 63(2):108–132CrossRefGoogle Scholar
  3. 3.
    Ashdown BC, Tien RD, Felsberg GJ (1994) Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 162(1):155–159PubMedGoogle Scholar
  4. 4.
    Walsh TJ, Hier DB, Caplan LR (1985) Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 18(5):574–582PubMedCrossRefGoogle Scholar
  5. 5.
    Siddiqui AA, Shah AA, Bashir SH (2004) Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases. Neurosurgery 55(3):602–611PubMedCrossRefGoogle Scholar
  6. 6.
    Kim DG, Hong SC, Kim HJ, Chi JG, Han MH, Choi KS, Han DH (1993) Cerebral aspergillosis in immunologically competent patients. Surg Neurol 40(4):326–331PubMedCrossRefGoogle Scholar
  7. 7.
    Alrajhi AA, Enani M, Mahasin Z, Al-Omran K (2001) Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia. Am J Trop Med Hyg 65(1):83–86PubMedGoogle Scholar
  8. 8.
    Szymanska J (2005) Evaluation of mycological contamination of dental unit waterlines. Ann Agric Environ Med 12(1):153–155PubMedGoogle Scholar
  9. 9.
    Curtis L, Cali S, Conroy L, Baker K, Ou CH, Hershow R, Norlock-Cruz F, Scheff P (2005) Aspergillus surveillance project at a large tertiary-care hospital. J Hosp Infect 59(3):188–196PubMedCrossRefGoogle Scholar
  10. 10.
    Sridhar H, Jayshree RS, Bapsy PP, Appaji L, Navin Kumar M, Shafiulla M, VijayKumar BR (2002) Invasive aspergillosis in cancer. Mycoses 45(9–10):358–363PubMedCrossRefGoogle Scholar
  11. 11.
    Yoshida K, Ando M, Ito K, Sakata T, Arima K, Araki S, Uchida K (1990) Hypersensitivity pneumonitis of a mushroom worker due to Aspergillus glaucus. Arch Environ Health 45(4):245–247PubMedCrossRefGoogle Scholar
  12. 12.
    Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, Lafe K, Bui U, Limaye AP, Cookson BT (2001) Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 39(11):4042–4051PubMedCrossRefGoogle Scholar
  13. 13.
    Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, LaFe K, Yarfitz SL, Limaye AP, Cookson BT (2000) Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin Microbiol 38(6):2302–2310PubMedGoogle Scholar
  14. 14.
    Rakeman JL, Bui U, LaFé K, Chen YC, Honeycutt RJ, Cookson BT (2005) Multilocus DNA sequence comparisons rapidly identify pathogenic molds. J Clin Microbiol 43(7):3324–3333PubMedCrossRefGoogle Scholar
  15. 15.
    Sutton DA, Fothergill AW, Rinaldi MG (1998) Guide to clinically significant fungi. Williams and Wilkins, Baltimore, p 54Google Scholar
  16. 16.
    St-Germain G, Summerbell R (1996) Identifying filamentous fungi. Star Publishing, Belmont, CA, p 68Google Scholar
  17. 17.
    Hussain S, Salahuddin N, Ahmad I, Salahuddin I, Jooma R (1995) Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. Eur J Radiol 20(2):151–155PubMedCrossRefGoogle Scholar
  18. 18.
    Lin SJ, Schrannz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32(3):358–366PubMedCrossRefGoogle Scholar
  19. 19.
    Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347(6):408–415PubMedCrossRefGoogle Scholar
  20. 20.
    Patterson TF, Kirkpatrick WR, White M et al (2000) Invasive aspergillosis. Disease, spectrum, treatment practices, and outcomes. 13 Aspergillus Study Group. Medicine (Baltimore) 79(4):250–260CrossRefGoogle Scholar
  21. 21.
    Araujo R, Pina-Vaz C, Rodrigues AG (2007) Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Int J Antimicrob Agents 29(1):108–111PubMedCrossRefGoogle Scholar
  22. 22.
    Black KE, Baden LR (2007) Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs 21(4):293–318PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • R. S. Traboulsi
    • 1
  • M. M. Kattar
    • 2
  • O. Dbouni
    • 1
  • G. F. Araj
    • 2
  • S. S. Kanj
    • 1
    • 2
  1. 1.Division of Infectious DiseasesAmerican University of Beirut Medical CenterHamra, BeirutLebanon
  2. 2.Department of Internal MedicineAmerican University of Beirut Medical CenterHamra, BeirutLebanon

Personalised recommendations